AU2003275846A1 - Methods for neuroprotection - Google Patents

Methods for neuroprotection

Info

Publication number
AU2003275846A1
AU2003275846A1 AU2003275846A AU2003275846A AU2003275846A1 AU 2003275846 A1 AU2003275846 A1 AU 2003275846A1 AU 2003275846 A AU2003275846 A AU 2003275846A AU 2003275846 A AU2003275846 A AU 2003275846A AU 2003275846 A1 AU2003275846 A1 AU 2003275846A1
Authority
AU
Australia
Prior art keywords
neuroprotection
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003275846A
Inventor
John Bechberger
Christian Naus
Mark A. Ozog
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of AU2003275846A1 publication Critical patent/AU2003275846A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003275846A 2002-10-24 2003-10-24 Methods for neuroprotection Abandoned AU2003275846A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42068102P 2002-10-24 2002-10-24
US60/420,681 2002-10-24
PCT/CA2003/001626 WO2004037281A1 (en) 2002-10-24 2003-10-24 Methods for neuroprotection

Publications (1)

Publication Number Publication Date
AU2003275846A1 true AU2003275846A1 (en) 2004-05-13

Family

ID=32176610

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003275846A Abandoned AU2003275846A1 (en) 2002-10-24 2003-10-24 Methods for neuroprotection

Country Status (2)

Country Link
AU (1) AU2003275846A1 (en)
WO (1) WO2004037281A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5349056A (en) * 1992-10-09 1994-09-20 Regeneron Pharmaceuticals Modified ciliary neurotrophic factors
ATE324906T1 (en) * 2000-09-14 2006-06-15 Ares Trading Sa USE OF CHIMERIC IL6-IL6R IN HUNTINGTON'S DISEASE
WO2002064021A2 (en) * 2001-02-12 2002-08-22 Baylor College Of Medicine Methods and compositions for control of bone formation via modulation of ciliary neurotrophic factor activity

Also Published As

Publication number Publication date
WO2004037281A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
AU2003266949A1 (en) Compounds
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003258549A1 (en) Maldi-matrix
AU2003278355A1 (en) Process
AU2003258070A1 (en) Electrodionization method
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003221050A1 (en) Remedy for hypermyotonia
AU2003253813A1 (en) Method for colpoplasty
AU2003210892A1 (en) Process for vinyl acetate
AU2003292667A1 (en) Benzocycloheptapyridine compounds
AU2002318053A1 (en) Suplier
AU2003264722A1 (en) Methods
AU2003263197A1 (en) Process
AU2003278535A1 (en) Histoscreen method
AU2003255322A1 (en) Compounds
AU2003243143A1 (en) 2-methyl-thieno-benzodiazepine process
AU2003275846A1 (en) Methods for neuroprotection
AU2003275480A1 (en) Compounds
AU2003903723A0 (en) Process
AU2003260250A1 (en) Method for position determination
AU2002367923A1 (en) Method for preparing 2-alkoxyphenoxyethanamines from 2-alkoxyphenoxyethylacetamides
AUPS145102A0 (en) Methods
AU2002100186A4 (en) Fonepark advanced
AU2002100482A4 (en) Tail-gate-ezy
AU2002100498A4 (en) Linline

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase